Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT).

Journal of gynecologic oncology（2023）

引用 0|浏览31

暂无评分

摘要

ClinicalTrials.gov Identifier: NCT05179447.

查看译文

关键词

Clinical Trials, Phase III as Topic,Complementary Therapies,Endometrial Neoplasms,Pathology, Molecular

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要